QlikTech, (NASDAQ: QLIK), a leader in user-driven Business Intelligence (BI), today announced that it has secured the highest overall ranking among enterprise BI and analytics vendors according to the “Healthcare Analytics: Making Sense of the Puzzle Pieces” 1 report published by KLAS, a research firm specializing in monitoring and reporting healthcare vendor performance. QlikTech’s overall ranking and rating is based on direct feedback from healthcare providers who have used the QlikView Business Discovery platform across their enterprise and measures software performance in areas such as product quality, implementation, and support.
With an overall rating of 85.7, QlikTech was noted for visual data discovery and ranked highest among other ranked vendors in areas such as overall satisfaction and ease of use. One customer reported that “It is easy to ingest the information in QlikView, and the data doesn’t have to be modeled and designed to the degree that the data in MicroStrategy and BusinessObjects does to provide insight.” Another customer said, “A key highlight of QlikView is that the users love it. I owe quite a substantial amount of the success of what we have been doing with business intelligence so far to the user adoption of QlikView. Essentially, after a few minutes, very nontechnical people can use QlikView, and they love using it.”
QlikTech also exceeded its competitors in key performance ratings for quality of training, product response time, delivery of new technology, and lives up to expectations. Among those ranked, it is the highest vendor ranked for money’s worth. Additionally, 100 percent of clients surveyed indicate that they would purchase QlikView again and that service and support “keeps promises”. According to a VP of a large health system, “… QlikView’s in-memory capabilities and nearly best-in-class visualization together offer an end-user experience we have been unable to duplicate with other tools. Our user satisfaction is very high. This is the best experience we have had with a BI product.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts